Measuring the Volumes of Hypertrophic Scars and Keloids, Two Specific Kind of Scars, Over Different Points in Time in Patients Who Have Undergone Surgery and Evaluate 3D-cameras As a Possible Measuring and Documenting Tool Including Volumetry
Quantification of Hypertrophic Scar Tissue or Keloid Using a 3D-Camera
1 other identifier
observational
20
1 country
1
Brief Summary
Measuring the volumes of hypertrophic scars and keloids, two specific kind of scars, over different points in time in patients who have undergone surgery and evaluate 3D-cameras as a possible measuring and documenting tool including volumetry.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 10, 2025
CompletedFirst Submitted
Initial submission to the registry
January 21, 2025
CompletedFirst Posted
Study publicly available on registry
February 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedFebruary 7, 2025
February 1, 2025
9 months
January 21, 2025
February 4, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Measurability
The objective of this study is to determine the feasibility of utilizing 3D cameras to accurately measure hypertrophic scars and keloids. The primary outcome of this study is the measurement of the volumes of hypertrophic scars in cubic millimeters (equivalent to milliliters) over a period of one year. This will allow for an evaluation of the accuracy of 3D photography and for the observation of any potential changes.
Day 0, Month 3, 6 and 12
Interventions
3D-Pictures will be taken of hypertrophic scars and keloids to document them.
Eligibility Criteria
Patients with hypertrophic scars or keloids of the University Hospital Zurich
You may qualify if:
- All patients with hypertrophic scars or keloids, written consent to participate in the study, minimum age of 18 years.
You may not qualify if:
- Absence of written consent, unwillingness to contribute data, inability to understand the study protocol.
- lack of hypertrophic scars or keloid
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universitätsspital Zürich
Zurich, Canton of Zurich, 8091, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 21, 2025
First Posted
February 4, 2025
Study Start
January 10, 2025
Primary Completion
September 30, 2025
Study Completion
September 30, 2025
Last Updated
February 7, 2025
Record last verified: 2025-02